The article examines the issue surrounding the approval of a genetically engineered Atlantic salmon by the U.S. Food and Drug Administration for public consumption. Topics discussed include the genetic engineering of the fish conducted by AquaBounty and the review of genetically engineered animals as "new animal drugs." The failure of the agency to consider the environmental impact of genetically engineered animals is mentioned.